Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees

April 28, 2023 updated by: Joan Sanders, University of Washington

Portable Bioimpedance Monitoring: Testing a New Diagnostic Interface

The purpose of the proposed study is to conduct research on individuals with lower limb amputation, evaluating if residual limb fluid volume data collected using a novel non-invasive device is beneficial towards prosthetic prescription, fit, and comfort as determined by amputee test subjects and practitioners (prosthetists). Participants' residual limb fluid volume will be monitored through bioimpedance analysis both before and after a practitioner-issued modification to the prosthesis as an observational cohort study and then as a blinded randomized control trial in which the data may or may not be shared with the practitioner before the modification is made to the prosthesis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98105
        • University of Washington Bioengineering

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Transtibial amputees, unilateral or bilateral
  • Amputation at least 18 months prior
  • Walking activity of at least 7 hours per week
  • Medicare functional classification level of 2 or higher
  • Residual limb length of at least 9 centimeters
  • Detrimental impacts to socket fit caused by residual limb volume fluctuations
  • Indication for augmented suspension, socket modification/change, sock application removal or activity modification

Exclusion Criteria:

  • Incidence of skin breakdown
  • Inability to ambulate continuously on a level walkway

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Arm 1
In Arm 1, bioimpedance measurements are taken by research staff. The participants also wear an ActiGraph monitor for at least one week prior to their prosthetist preforming modifications to their socket.
Experimental: Arm 2 - Experimental
Conclusions drawn from data gathered in Arm 1 will be given to the participant's prosthetist, along with their bioimpedance data from Arm 2, to inform the practitioner's decision on when a modification to the socket is warranted. The results will be compared to those of Arm 3.
Participant in aim 1 will be monitored using the bioimpedance monitor. Data obtained from the arm 1 cohort will be used to inform socket modifications made for arm 2 cohort.
No Intervention: Arm 3 - Control
Bioimpedance data will be collected from participants in Arm 3 in parallel with those in Arm 2. However, no data will be provided to the participant's prosthetist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Significant Increases in Socket Comfort Score (SCS)
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Participants are asked to quantify the overall comfort of their prosthesis by giving it a score between 0 and 10 with 0 as the least comfortable possible and 10 being the most comfortable possible. SCS scores were acquired both pre and post making modifications to the participant's prosthesis. For analysis purposes, the number of participants that had a significant positive change are counted for this outcome. Participants that had little to no change (a score difference <2) in SCS or had a negative change in SCS score were not counted.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Net-Positive Increase in Prosthesis Satisfaction, Measured by the Patient's Overall Satisfaction With Their Entire Prosthesis
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Participants are asked to indicate their overall satisfaction with their prosthesis by drawing a line on a continuous scale running from extremely unhappy to extremely happy (0 to 100). For analysis purposes, the number of participants that had a net positive change are counted for this outcome. Participants that had a net negative or no change were not counted.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Number of Participants With Net-Positive Change in Ambulation Score
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Participants are asked to indicate their overall ability to walk with their prosthesis by drawing a line on a continuous scale running from "Cannot Walk at All" to "No Problem Walking" (0 to 100, respectively). They are also asked questions related to ambulation ability in unique circumstances, such as walking in close spaces, up and down stairs, up and down hills, on streets, on sidewalks, and on slippery surfaces. For analysis purposes, the number of participants that had a net positive change are counted for this outcome. Participants that had a net negative or no change were not counted.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Number of Participants With Net-Positive Change in Residual Limb Health Score
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Participants are asked to indicate how much their residual limb sweats, smells, swells, develops rashes, develops ingrown hairs, and develops blisters, while wearing their prosthesis.They indicate this by drawing a line on a continuous scale running from "Extreme Amount" to "Not At All" (0 to 100, respectively). For analysis purposes, the number of participants that had a net positive change are counted for this outcome. Participants that had a net negative or no change were not counted.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Number of Participants With Net-Positive Change in Prosthesis Utility Score
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Participants are asked to indicate various features related to the utility of their prosthesis by drawing a line on a continuous scale that ranges from "Terrible" to "Excellent" (0 to 100, respectively). Features include prosthesis fit, weight, comfort while standing, comfort while sitting, balance, effort, feel, and donning. For analysis purposes, the number of participants that had a net positive change are counted for this outcome. Participants that had a net negative or no change were not counted.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Number of Participants With Net-Positive Change in Prosthesis Well Being Score
Time Frame: Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Prosthesis users indicate their well being since their amputation and also rank their overall quality of life by marking a line on a scale ranging from "worst possible life" to "best possible life" (0 to 100, respectively). Participants who showed a positive net increase in this category were counted for each aim.
Baseline taken pre-modification, with a final score taken post-modification. The minimum time between scores was 3 weeks.
Prosthetist Communication Assessment Score, Measured by the Communication Efficacy Between the Prosthetist and Their Patient
Time Frame: Baseline, prior to socket modification
Participants' prosthetists are asked to rate their ability to communicate the need for sock or behavioral changes to their patients participating in the study. They will indicate the score using a scale from 0 to 10 with 10 being the best possible communication and 0 being the worst possible communication.
Baseline, prior to socket modification
Types of Socket Modifications Implemented Per Group
Time Frame: Baseline, prior to socket modification
Participants' prosthetists are asked the type of socket modification(s) that they implemented in free response format. Responses were simplified into 5 categories related to common modification changes. The most common themes were: fabrication of a new socket, addition of socket pads or an insert, creating socket reliefs, changing socket suspension, and other. Changes that fell under the "other" category were not necessarily related to changes in socket shape, such as changes in overall prosthesis alignment, prosthesis foot, fabrication materials, etc.
Baseline, prior to socket modification
Effect of Socket Modification, Measured by the Impact of the Physical Modification Made to the Prosthesis to Socket Fit
Time Frame: Post modification, minimum 4 weeks after patient started study
Participants' prosthetists from both groups were asked to rate the effectiveness of the modification(s) that they implemented on a scale of 0 to 10 in which 10 is "Excellent" and 0 is "Terrible".
Post modification, minimum 4 weeks after patient started study
Strategies Recommended to Minimize Limb Fluid Volume Loss
Time Frame: Post modification, minimum 4 weeks after patient started study
Participants' prosthetists are asked what changes to the participant's volume management strategy they recommended in free-response format. The following common themes were pulled from their responses: new sock regimen, periodic doffing, new activity regimen, new self-care regimen, other, and none. A count for how many prosthetists mentioned the same theme was tabulated.
Post modification, minimum 4 weeks after patient started study
Effect of Volume Management Strategy, Measured by the Impact of the Changes in Volume Management to Socket Fit
Time Frame: Post modification, minimum 4 weeks after patient started study
Participants' prosthetists are asked to rate the effectiveness of the strategies that they recommended on a scale of 0 to 10 in which 10 is "Excellent" and 0 is "Terrible".
Post modification, minimum 4 weeks after patient started study
Modification/Strategy Satisfaction, Measured by Overall Satisfaction of All Methods Employed
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to rate their overall satisfaction with the socket modification and/or volume management change that was used for each participant by indicating a score from 0 to 10 with 10 being "Extremely Satisfied" and 0 being "Not Satisfied".
Post modification, minimum 4 weeks after patient started study
Prosthetist Impression of Bioimpedance Results, Measured by General Feedback From Clinicians on the Bioimpedance Data They Are Given
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to describe their impression of the bioimpedance results in a free response format. Common themes were gathered from responses and a count for each was tabulated based on gathered responses.
Post modification, minimum 4 weeks after patient started study
Prosthetist Use of Bioimpedance Results, Measured by General Feedback on How the Clinicians Use the Bioimpedance Data They Are Given
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to describe, in free response format how they used the bioimpedance results to inform their clinical practice. Common themes were gathered from responses and a count for each was tabulated based on gathered responses.
Post modification, minimum 4 weeks after patient started study
Bioimpedance Usefulness for Socket Design, Measured by General Feedback on How Useful Bioimpedance is for Informing Decisions on Socket Modifications
Time Frame: Post modification, minimum 4 weeks after patient started study
Participants' prosthetists are asked to rate the effectiveness of the strategies that they recommended on a scale of 0 to 10 in which 10 is "Very Useful" and 0 is "Not Useful".
Post modification, minimum 4 weeks after patient started study
Bioimpedance for Volume Management, Measured by General Feedback on How Useful Bioimpedance is for Informing Decisions on Socket Modifications
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to rate the utility of bioimpedance results in recommending volume management strategies to their patients. The rating scale is 0 to 10 with 10 being "Very Useful" and 0 being "Not Useful".
Post modification, minimum 4 weeks after patient started study
Continuing Use of Bioimpedance Results, Measured by How Likely Clinicians Will be to Use Bioimpedance Data in the Future
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to indicate how likely they are to request bioimpedance data for their other patients by selecting a score from 0 to 10 with 10 with being "Very Likely" and 0 being "Not Likely at All".
Post modification, minimum 4 weeks after patient started study
Impact of Bioimpedance, Measured by How Bioimpedance Data Changed the Way Prosthetists Approach Problem Issues of Socket Fit
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to quantify the impact that the bioimpedance had on the manner in which they approached the issue by rating the impact from 0 to 10 with 10 being "Very Impactful" and 0 being "No Impact".
Post modification, minimum 4 weeks after patient started study
Most Useful Bioimpedance Data, Measured by Which Element of the Bioimpedance Data is Most Useful to Clinicians
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to select from a list which bioimpedance data was most useful to them. The list items are: magnitude of fluid volume change over the whole day, fluid volume change by regions of the limb, fluid volume change from different activities, rate of fluid volume change over the whole day, and rate of fluid volume change over specific activity intervals
Post modification, minimum 4 weeks after patient started study
Bioimpedance and Communication Measured by General Feedback on Whether Prosthetist-patient Communication is Improved Through Use of Bioimpedance Data
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to indicate the degree to which their use bioimpedance results improved the communication between them and their patients. They indicate this by selecting a value from 0 to 10 with 10 being "Highly Impactful" and 0 being "No Impact".
Post modification, minimum 4 weeks after patient started study
Outcome Enhancement, Measured by the Degree to Which Outcomes Are Improved Using Bioimpedance Data
Time Frame: Post modification, minimum 4 weeks after patient started study
Prosthetists are asked to indicated the degree to which clinical outcomes were enhanced by the use of bioimpedance results. They indicate this by selecting a value from 0 to 10 with 10 being "Positive Impact" and 0 being "Negative Impact".
Post modification, minimum 4 weeks after patient started study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joan E Sanders, PhD, University of Washington

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 9, 2016

Primary Completion (Actual)

September 14, 2020

Study Completion (Actual)

December 23, 2020

Study Registration Dates

First Submitted

March 16, 2017

First Submitted That Met QC Criteria

May 19, 2017

First Posted (Actual)

May 23, 2017

Study Record Updates

Last Update Posted (Actual)

May 3, 2023

Last Update Submitted That Met QC Criteria

April 28, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00000969

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transtibial Amputee

Clinical Trials on Bioimpedance monitor

3
Subscribe